Substantially with the legislative action has stemmed from Purdue Pharma's conclusion in 2011 to start a modification of Oxycontin's composition to really make it more difficult to crush for snorting or injecting. The new formulation, OxyNeo, is meant to become preventive in this regard and retain its usefulness for a painkiller. Due to the fact in